+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023 - Product Image

Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023

  • ID: 4832540
  • Report
  • August 2019
  • Region: Global
  • 123 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 23andMe Inc.
  • Invitae Corp.
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.
  • MORE
Global Direct-to-consumer Genetic Testing Market: About this market

The direct-to-consumer genetic testing market analysis considers sales from both direct sales and retail sales. Our analysis also considers the sales of direct-to-consumer genetic testing in Asia, Europe, North America, and ROW. In 2018, the direct sales segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as a reduction in additional costs involved in distribution and logistics will play a significant role in the direct sales segment to maintain its market position. Also, our global direct-to-consumer genetic testing market report looks at factors such as growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits. However, doubts over-analytical and clinical validity, limited reimbursement policies, and concerns over safety and privacy of personal data may hamper the growth of the direct-to-consumer genetic testing industry over the forecast period.

Global Direct-to-consumer Genetic Testing Market: Overview

Growing adoption of direct-to-consumer genetic testing in early disease diagnosis

The adoption of direct-to-consumer genetic testing has increased, especially among people with a family history of certain diseases with a greater chance of their genetic transmission to their progeny. The increasing number of people with Alzheimer, cancer, and Parkinson’s disease has fueled the demand for these tests. Direct-to-consumer genetic testing kit helps in the early diagnosis of diseases and help approach physicians for further monitoring and prevention. This will lead to the expansion of the global direct-to-consumer genetic testing market at a CAGR of over 16% during the forecast period.

Growing adoption of online service platforms

The increase in the adoption of digital trends in the healthcare industry has enabled vendors to have the edge over their competitors by offering better healthcare services. Online ordering facilities has increased the propensity of the consumers to avail more direct-to-consumer genetic tests. This leads the companies to provide attractive discounts to promote sales through online platforms. The availability of a digital database of consumers helps companies to analyze the performance of their products and improve through constant development and upgrades. This adoption of online service platforms is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of several major players, the global direct-to-consumer genetic testing market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct-to-consumer genetic testing manufacturers, that include 23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., Quest Diagnostics Inc.

Also, the direct-to-consumer genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 23andMe Inc.
  • Invitae Corp.
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
  • Market segmentation by distribution channel
  • Comparison by distribution channel
  • Direct sales - Market size and forecast 2018-2023
  • Retail sales - Market size and forecast 2018-2023
  • Market opportunity by distribution channel
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY SERVICE
  • Market segmentation by service
PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Advances in next-generation genetic sequencing
  • Reduction in the cost of services
  • Growing adoption of online service platforms
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Distribution channel - Market share 2018-2023 (%)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Direct sales - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Direct sales - Year-over-year growth 2019-2023 (%)
Exhibit 22: Retail sales - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Retail sales - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: Customer landscape
Exhibit 26: Global direct-to-consumer genetic testing market: Segmentation by service 2018 (%)
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: andMe Inc. - Vendor overview
Exhibit 46: andMe Inc. - Business segments
Exhibit 47: andMe Inc. - Organizational developments
Exhibit 48: andMe Inc. - Key offerings
Exhibit 49: Invitae Corp. - Vendor overview
Exhibit 50: Invitae Corp. - Business segments
Exhibit 51: Invitae Corp. - Organizational developments
Exhibit 52: Invitae Corp. - Geographic focus
Exhibit 53: Invitae Corp. - Key offerings
Exhibit 54: Laboratory Corp. of America Holdings - Vendor overview
Exhibit 55: Laboratory Corp. of America Holdings - Business segments
Exhibit 56: Laboratory Corp. of America Holdings - Organizational developments
Exhibit 57: Laboratory Corp. of America Holdings - Geographic focus
Exhibit 58: Laboratory Corp. of America Holdings - Segment focus
Exhibit 59: Laboratory Corp. of America Holdings - Key offerings
Exhibit 60: Myriad Genetics Inc. - Vendor overview
Exhibit 61: Myriad Genetics Inc. - Business segments
Exhibit 62: Myriad Genetics Inc. - Organizational developments
Exhibit 63: Myriad Genetics Inc. - Segment focus
Exhibit 64: Myriad Genetics Inc. - Key offerings
Exhibit 65: Quest Diagnostics Inc. - Vendor overview
Exhibit 66: Quest Diagnostics Inc. - Business segments
Exhibit 67: Quest Diagnostics Inc. - Organizational developments
Exhibit 68: Quest Diagnostics Inc. - Geographic focus
Exhibit 69: Quest Diagnostics Inc. - Segment focus
Exhibit 70: Quest Diagnostics Inc. - Key offerings
Exhibit 71: Validation techniques employed for market sizing
Exhibit 72: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • 23andMe Inc.
  • Invitae Corp.
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.
  • MORE
The following companies are recognised as the key players in the global direct-to-consumer genetic testing market: 23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., Quest Diagnostics Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing adoption of online service platforms.”

According to the report, one of the major drivers for this market is the growing adoption of direct-to-consumer genetic testing in early disease diagnosis

Further, the report states that one of the major factors hindering the growth of this market is the concerns over the safety and privacy of personal data.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.
Note: Product cover images may vary from those shown
Adroll
adroll